SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMediumNeutral
Announced Fri, 22 May · 15:08 IST

Shilpa Medicare Limited has informed the Exchange regarding Notice of Postal Ballot

Board & Shareholder Meetings View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.1%1-day move
₹476.00
prior close
₹490.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-1.3-2.2+8.1+6.3+3.6+4.0+4.5+8.3+11.9+15.3+28.7
Up moveDown movePending
AI summary

Shilpa Medicare Limited has issued a postal ballot notice seeking shareholder approval for relocating its registered office from Raichur, Karnataka to Andheri (East), Mumbai, Maharashtra. The Board of Directors approved this proposal on 22 May 2026. The company states the relocation is driven by business and administrative considerations, as Mumbai being the financial and commercial hub provides better access to financial institutions, regulatory authorities, potential business associates, and investors. Key customers and a significant number of shareholders are located in Mumbai. The company has clarified that no employees will be retrenched as a consequence of this shifting. Shareholders can cast their votes electronically from 24 May 2026 until 22 June 2026. The resolution requires shareholder approval via special resolution and is subject to further approval from the Regional Director under the Companies Act, 2013.

Likely market impact

This is a routine corporate relocation that is unlikely to have a direct material impact on the stock price or operations. However, the move to Mumbai may improve investor engagement and access to capital markets, which could be mildly positive for shareholder visibility over the long term.